AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)
AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)

Financial Summary MDXG Quote MiMedx Grou

MiMedx Group Inc Quote

MiMedx Group In (MDXG)

3.66 -0.8 Healthcare
Stock Performance rating :
Recommendation :
Not Available
Symbol MDXG
Price 3.66
Beta 1.22
Vol Avg 5.00 M
Mkt cap 406.39 M
Shares 113
Last Div Not Available
Div Yield 0.00%
DCF Unlevered Not Available Not Available
DCF Levered Not Available Not Available
ROE Not Available Not Available
ROA Not Available Not Available
Operating Margin Not Available Not Available
Debt/Equity Not Available Not Available
P/E Not Available Not Available
P/B Not Available Not Available
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 27 59 118 0 0
COGS 5 9 13 20 32
GrossProfit 22 50 106 167 213
Depreciation (included in COGS) 2 2 2 0 0
StockBasedCompe (included in COGS) 3 6 11 17 18
ResearchAndDeve 3 5 7 8 12
SalesGeneralAnd 21 46 90 133 180
OperatingIncome -2 -2 7 24 18
InterestExpense 1 0 0 0 0
OtherIncome -5 -2 0 0 0
IncomeBeforeTax -8 -4 7 24 18
ProvisionForInc 0 0 0 0 0
NetIncome -8 -4 6 29 12
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 7 44 47 28 34
ShortTermInvest 0 0 6 3 0
Cash 7 44 52 0 0
AccountReceivab 8 16 27 0 0
Inventories 3 4 5 0 0
DeferredIncomeT 0 0 0 15 9
OtherCurrentAss 0 0 0 0 1
TotalCurrentAss 18 65 86 96 127
PPE 3 6 9 14 22
AccumulatedDepr -2 -2 -3 -5 -9
NetPPE 1 4 5 9 14
EquityAndOtherI 0 0 3 0 0
Goodwill 4 4 4 4 20
IntangibleAsset 12 11 11 11 23
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 17 19 24 40 67
TotalAssets 35 85 109 136 193
ShortTermDebt 0 0 0 0 0
AccountsPayable 1 2 4 0 0
TaxesPayable 0 0 0 0 6
AccruedLiabilit 4 1 3 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 6 12 16 10
TotalCurrentLia 5 10 18 27 51
Debt 4 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 6 2 2 1 10
TotalNonCurrent 10 2 2 1 10
TotalLiabilitie 15 11 20 28 60
CommonStock 0 0 0 0 0
AdditionalPaidI 90 147 162 163 161
RetainedEarning -70 -74 -68 -38 -26
AccumulatedOthe 0 0 0 0 0
TotalStockholde 20 74 89 108 133
TotalLiabilitie 35 85 109 136 193
Cash Flow Statement
Year 20142015201620172018
NetIncome -8 -4 6 29 12
Depreciation 2 2 2 0 0
DeferredIncomeT 0 0 0 -7 -1
StockBasedCompe 3 6 11 17 18
AccountsReceiva -6 -8 -11 -27 -11
InventoryCS -2 -1 -1 -2 -3
AccountsPayable 0 1 1 3 -4
OtherWorkingCap 0 0 1 -1 0
OtherNonCashIte 2 0 0 0 0
NetCashProvided -3 0 17 19 26
InvestmentsInPP -1 -2 -3 -6 -6
AcquisitionsNet 0 0 0 0 -8
PurchasesOfInve 0 0 -9 0 0
SalesMaturities 0 0 0 0 3
PurchasesOfInta 0 -1 -1 -1 -1
OtherInvestingA 0 0 0 6 0
NetCashUsedForI -1 -3 -12 -1 -12
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 0 0
CommonStockIssu 0 37 0 0 0
CommonStockRepu 0 0 -6 -40 -12
DividendPaid 0 0 0 0 0
OtherFinancingA 7 4 4 4 3
NetCashProvided 7 41 -2 -36 -8
NetChangeInCash 3 37 3 -18 6
CashAtBeginning 4 7 44 47 28
CashAtEndOfPeri 7 44 47 28 34
Retained Earnings
Year 20142015201620172018
RetainedEarning ----70-74
NetIncome ---8-46
StockDividend --788-12
DividendPaid -----
RetainedEarning ---70-74-68
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ---14
DeprAnnual 0--2--1
CapitalExpendit 00133
NetPPE --145
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0--1615
Amortization 0---2-1
NewPurchases 0-1611
intAndGW --161515
Company Profile

CEO

Parker H. Petit

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ Capital Market

Description

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.